Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr;27(4):1154-1161.
doi: 10.1007/s10461-022-03852-w. Epub 2022 Oct 8.

Does It Matter What Screener We Use? A Comparison of Ultra-brief PHQ-4 and E-mwTool-3 Screeners for Anxiety and Depression Among People With and Without HIV

Affiliations

Does It Matter What Screener We Use? A Comparison of Ultra-brief PHQ-4 and E-mwTool-3 Screeners for Anxiety and Depression Among People With and Without HIV

Cale N Basaraba et al. AIDS Behav. 2023 Apr.

Abstract

The burden of depression and anxiety disorders is high in sub-Saharan Africa, especially for people with HIV (PWH). The Patient Health Questionnaire-4 (PHQ-4) and Electronic Mental Wellness Tool-3 (E-mwTool-3) are ultra-brief screening tools for these disorders. We compared the performance of PHQ-4 and E-mwTool-3 for screening MINI-International Neuropsychiatric Interview diagnoses of depression and anxiety among a sample of individuals with and without HIV in two primary care clinics and one general hospital in Maputo City, Mozambique. Areas-under-the-curve (AUC) were calculated along with sensitivities and specificities at a range of cutoffs. For PWH, at a sum score cutoff of ≥ 1, sensitivities were strong: PHQ-4:Depression = 0.843; PHQ-4:Anxiety = 0.786; E-mwTool-3:Depression = 0.843; E-mwTool-3:Anxiety = 0.929. E-mwTool-3 performance was comparable to PHQ-4 among people with and without HIV.

Keywords: Anxiety; Brief screeners; Depression; GAD-2; HIV; PHQ-2; PHQ-4; Sub-Saharan Africa.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Dr. Oquendo reports receipt of royalties from the Research Foundation for Mental Hygiene for the commercial use of the Columbia Suicide Severity Rating Scale. She serves as an advisor to Alkermes, Otsuka, Mind Medicine, St. George’s University and Fundacion Jimenez Diaz. Her family owns stock in Bristol Myers Squibb. The other authors report no financial relationships with commercial interests.

References

    1. Halsted S, Ásbjörnsdóttir KH, Wagenaar BH, Cumbe V, Augusto O, Gimbel S, et al. Depressive symptoms, suicidal ideation, and mental health care-seeking in central Mozambique. Soc Psychiatry Psychiatr Epidemiol. 2019;54(12):1519–33. - PMC - PubMed
    1. Chibanda D, Cowan FM, Healy JL, Abas M, Lund C. Psychological interventions for common mental disorders for people living with HIV in low- and middle-income countries: systematic review. Trop Med Int Health. 2015;20(7):830–9. - PubMed
    1. Lund C, Breen A, Flisher AJ, Kakuma R, Corrigall J, Joska JA, et al. Poverty and common mental disorders in low and middle income countries: a systematic review. Soc Sci Med. 2010;71(3):517–28. - PMC - PubMed
    1. Greene MC, Yangchen T, Lehner T, Sullivan PF, Pato CN, McIntosh A, et al. The epidemiology of psychiatric disorders in Africa: a scoping review. Lancet Psychiatry. 2021;8(8):717–31. - PMC - PubMed
    1. Ayano G, Solomon M, Abraha M. A systematic review and metaanalysis of epidemiology of depression in people living with HIV in east Africa. BMC Psychiatry. 2018;18(1):254. - PMC - PubMed